Thoracoabdominal Aortic Aneurysms
6
2
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
8 treatments under study, led by Custodiol
Research Leaders
7 sponsors active, led by Lifetech Scientific (Shenzhen) Co., Ltd.
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.4% vs benchmark
17%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (6)
Thoracoabdominal Artery Stent Graft System Exploratory Study
Safety and Efficacy of a Multi-branched Thoracoabdominal Stent Graft System for Thoracoabdominal Aortic Aneurysm.
Visceral Manifold Study for the Repair of TAAA
Visceral Manifold Study for the Repair of Thoracoabdominal Aortic Aneurysms
A PROpensity Score Matching Analysis on ENDovascular vs Open Thoraco-Abdominal Aortic Aneurysm Repair (PRO-ENDO TAAA Study)
CUstodiol Versus RInger: whaT Is the Best Agent?
Research Network
Common Treatments
- Custodiol1
- Endovascular Repair1
- Valiantthoracoabdominal Stent Graft System1
- Multibranched Thoracoabdominal Stent Graft System1
- Taaa Debranching Stent Graft System1
Active Sponsors
- Lifetech Scientific (Shenzhen) Co., Ltd.2
- IRCCS San Raffaele1
- Medtronic1
- NYU Langone Health1
- Scientific Institute San Raffaele1
Top Investigators
University of South Florida
Chinese PLA General Hospital
NYU Langone Health